Page last updated: 2024-10-24

chloroquine and Diabetic Glomerulosclerosis

chloroquine has been researched along with Diabetic Glomerulosclerosis in 2 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Liu, S1
Gao, X1
Fan, Z1
Wang, Q1
Jeong, HY1
Kang, JM1
Jun, HH1
Kim, DJ1
Park, SH1
Sung, MJ1
Heo, JH1
Yang, DH1
Lee, SH1
Lee, SY1

Other Studies

2 other studies available for chloroquine and Diabetic Glomerulosclerosis

ArticleYear
SIRT2 Affects Cell Proliferation and Apoptosis by Suppressing the Level of Autophagy in Renal Podocytes.
    Disease markers, 2022, Volume: 2022

    Topics: Animals; Apoptosis; Autophagy; Cell Proliferation; Chloroquine; Diabetic Nephropathies; Female; Gluc

2022
Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy.
    Scientific reports, 2018, 06-08, Volume: 8, Issue:1

    Topics: Amodiaquine; AMP-Activated Protein Kinases; Animals; Antimalarials; Cell Line; Chloroquine; Diabetes

2018